A portable device that detects eye
conditions that can cause sight loss in people with conditions
such as diabetes has received clearance from the U.S. health
regulator, its developers Optomed Oyj and.
A portable device that detects eye conditions that can cause sight loss in people with conditions such as diabetes has received clearance from the U.S. health regulator, its.
Optomed has established a Scientific Advisory Board
News provided by
Share this article
Share this article
HELSINKI, Jan. 28, 2021 /PRNewswire/ Optomed has established an international scientific advisory board. The board consists of globally recognized and scientifically merited medical doctors specializing in ophthalmology and neuro-ophthalmology, with advanced experience on artificial intelligence applied to detection of ophthalmic conditions.
The scientific advisory board consists of the following members:
Robert Chang, MD, Associate Professor of Ophthalmology, Stanford University Medical Center, USA
Nina Hautala, MD, PhD, Professor of Ophthalmology, Oulu University Hospital, Finland
Dan Milea, MD, PhD, Professor of Ophthalmology, Head, Visual Neuroscience Group, Singapore Eye Research Institute, Singapore National Eye Centre and Duke-NUS Medical School, Singapore